PCMC Details Massive Dilutive Reverse Merger with Physicians Capital, Cash Down to $6,692
Summary
PCMC's 10-Q details a reverse merger with Physicians Capital Management that will dilute existing holders to ~20% ownership. The company has only $6,692 in cash and a going concern warning, making the deal's completion critical for survival.
Key Events · M&A and Partnerships · PCMC
-
Reverse Merger Terms Quantified
Physicians' sole shareholder will receive 68,566,368 common shares and 24,913,918 preferred shares (Series A, B-1, B-2) in exchange for all Physicians shares, leaving existing PCMC holders with approximately 20% of the combined company.
-
Preferred Stock Conversion Features
Series B-1 (15.9M shares) converts at 4:1 after 18 months; Series B-2 (7.97M shares) converts at 8:1 after 24 months, potentially adding up to ~127.5 million common shares upon conversion, further diluting existing holders.
-
Cash Position Critical
Cash fell to $6,692 as of June 30, 2026, from $234,405 at September 30, 2025. The company has a working capital deficit of $322,851 and an accumulated deficit of $5.85 million.
-
Going Concern Warning Reiterated
The company's independent auditors have expressed substantial doubt about its ability to continue as a going concern. Survival depends on completing the business combination or obtaining other financing.
Analysis · PCMC · Real Estate & Construction
This 10-Q reveals the full terms of the June 30, 2026 Share Exchange Agreement with Physicians Capital Management. Existing PCMC shareholders will be diluted to approximately 20% ownership as Physicians' sole shareholder receives 68.6 million common shares and 24.9 million preferred shares with aggressive conversion features. The company's financial condition is dire: cash has dwindled to $6,692, a working capital deficit of $322,851 persists, and the going concern warning is reiterated. The filing also confirms PCMC is a shell company, meaning post-closing Rule 144 resale restrictions will apply for one year. The deal is expected to close in Q3 2026, but failure to close would likely force the company to seek alternative financing or face dissolution.
At the time of this filing, PCMC was trading at $0.40 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $13.7M. The 52-week trading range was $0.00 to $0.68. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.